FDA Okays Aripiprazole for Acute Schizophrenia RelapseFDA Okays Aripiprazole for Acute Schizophrenia Relapse

The FDA has approved a labeling update for the long-acting injectable antipsychotic aripiprazole. News Alerts
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Psychiatry News Alert Source Type: news